Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Colorcon
McKesson
McKinsey
Moodys

Last Updated: November 19, 2019

DrugPatentWatch Database Preview

NASCOBAL Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Nascobal, and what generic alternatives are available?

Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. There are six patents protecting this drug and one Paragraph IV challenge.

The generic ingredient in NASCOBAL is cyanocobalamin. There are nine drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the cyanocobalamin profile page.

Drug patent expirations by year for NASCOBAL
Drug Prices for NASCOBAL

See drug prices for NASCOBAL

Drug Sales Revenue Trends for NASCOBAL

See drug sales revenues for NASCOBAL

Recent Clinical Trials for NASCOBAL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Swedish Orphan BiovitrumPhase 1

See all NASCOBAL clinical trials

Recent Litigation for NASCOBAL

Identify potential future generic entrants

District Court Litigation
Case NameDate
ENDO PHARMACEUTICALS INC. v. LUPIN ATLANTIS HOLDINGS SA2018-06-22
Endo Pharmaceuticals Inc. v. Lupin Atlantis Holdings SA2017-07-28
Endo Pharmaceuticals Inc. v. Perrigo UK FINCO Limited Partnership

See all NASCOBAL litigation

Pharmacology for NASCOBAL
Drug ClassVitamin B12
Synonyms for NASCOBAL
0.1% Cobalamin Concentrate Trituration w/Mannitol
68-19-9
AB2000361
AKOS015894306
alpha-(5,6-Dimethylbenzimidazolyl)cyanocobamide
Anacobin
Bedoz
BEROCCA PN
Berubigen
Betaline-12
Betolvex
Bevidox concentrate
Biocobalamine
Byladoce
C63H88CoN14O14P
Cabadon M
CAS-68-19-9
CCG-220433
Cobadoce forte
cobalamin
Cobalamin;vitamin B-12;Cyanocobalamin
Cobavite
Cobinamide,dihydrogenphosphate(ester),inner salt,3'-ester with(5,6-Dimethyl-1-a-d-ribofuranosyl-1H-benzimidazole-kn3),ion(1+)(9ci)
Cobolin-M
Copharvit 5000
Covit
Crystamine
Crysti-12
Crystimin
Crystwel
Cyano-B12
Cyanobalamin concentrate
Cyanocob(III)alamin
cyanocobalamin
Cyanocobalamin (JP15/USP)
CYANOCOBALAMIN 0.1% IN MANNITOL
Cyanocobalamin;Cyanocob(III)alamin
Cyanocobalamine
Cyanocobalmin
cyanoject
Cycobemin
Cycolamin
Cykobemin
Cykobeminet
Cyomin
Cyredin
Cytacon
Cytamen
Cytobion
Depinar
Dicopac
Dimethylbenzimidazoylcobamide
Distivit
Docemine
Docibin
Docivit
Dodecabee
Dodecavite
Dodex
DSSTox_CID_24346
DSSTox_GSID_44346
DSSTox_RID_80159
DTXSID7044346
Duodecibin
Embiol
Emociclina
Eritrone
Erycytol
Erythrotin
Euhaemon
Extrinsic factor
Fermin
Fresmin
H486
Hemomin
Hepagon
Hepcovite
HMS1569G08
HMS2096G08
HMS3713G08
Hylugel plus
Macrabin
Megalovel
Milbedoce
Millevit
MolPort-016-633-264
Nagravon
NCGC00016302-01
NCGC00249888-01
Neuroforte-R
Normocytin
Novidroxin
Pernaemon
Pernaevit
Pernipuron
Plecyamin
Poyamin
Prestwick_564
Primabalt
Rebramin
Redamina
Redisol
Rhodacryst
Rubesol
RUBIVITE
Rubramin PC
RUBRATOPE-60 KIT
Rubripca
Rubrocitol
RUVITE
Shovite
Sytobex
Tox21_110358
Tox21_113664
V0344
Vi-Twel
Vibal
Vibalt
Vibisone
Virubra
Vita-rubra
Vitabee 12
vitamin B12
Vitamin B12 complex
Vitamin B12 preparation
Vitamine B12
Vitarubin
Vitral
Paragraph IV (Patent) Challenges for NASCOBAL
Tradename Dosage Ingredient NDA Submissiondate
NASCOBAL SPRAY, METERED;NASAL cyanocobalamin 021642 2017-04-28

US Patents and Regulatory Information for NASCOBAL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm NASCOBAL cyanocobalamin GEL, METERED;NASAL 019722-001 Nov 5, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes   Start Trial   Start Trial   Start Trial
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes   Start Trial   Start Trial   Start Trial
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes   Start Trial   Start Trial Y   Start Trial
Endo Pharms Inc NASCOBAL cyanocobalamin SPRAY, METERED;NASAL 021642-001 Jan 31, 2005 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Express Scripts
Merck
McKesson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.